Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P03950: Variant p.Pro136Leu

Angiogenin
Gene: ANG
Feedback?
Variant information Variant position: help 136 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Proline (P) to Leucine (L) at position 136 (P136L, p.Pro136Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In ALS9; loss of angiogenic activity; reduced ribonucleolytic activity; unable to translocate to the nucleus. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 136 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 147 The length of the canonical sequence.
Location on the sequence: help CQYRATAGFRNVVVACENGL P VHLDQSIFRRP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 25 – 147 Angiogenin
Active site 138 – 138 Proton donor
Mutagenesis 132 – 132 E -> A. Slightly decreases binding affinity for RNH1.
Mutagenesis 140 – 140 D -> HSA. 15- to 18-fold increase in RNase activity.
Mutagenesis 141 – 141 Q -> G. Over 18-fold increase in RNase activity.
Beta strand 135 – 139



Literature citations
Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis.
Wu D.; Yu W.; Kishikawa H.; Folkerth R.D.; Iafrate A.J.; Shen Y.; Xin W.; Sims K.; Hu G.-F.;
Ann. Neurol. 62:609-617(2007)
Cited for: VARIANTS ALS9 SER-20; ILE-41; ASN-52 AND LEU-136; CHARACTERIZATION OF VARIANTS ALS9 ILE-41; ASN-52 AND LEU-136; TISSUE SPECIFICITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.